Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Share News (ARIX)

  • There is currently no data for ARIX

ARIX.L News

Arix Bioscience net asset value falls at the end of January
7 Feb 2023

Arix Bioscience net asset value falls at the end of January

(Alliance News) - Arix Bioscience PLC said on Monday its net asset value at January 31 was 180 pence, down from 182p at the end of October, 2022.

Arix portfolio firm Disc Medicine seals Gemini Therapeutics merger
30 Dec 2022

Arix portfolio firm Disc Medicine seals Gemini Therapeutics merger

(Alliance News) - Arix Bioscience PLC on Friday said that its portfolio company has completed a previously announced merger with Gemini Therapeutics I...

IN BRIEF: Arix Bioscience Chair Moncreiffe buys 78,000 more shares
2 Nov 2022

IN BRIEF: Arix Bioscience Chair Moncreiffe buys 78,000 more shares

Arix Bioscience PLC - London-based venture capital investor in biotech firms - Chair Peregrine Moncreiffe buys 78,000 shares at GBP1.04 each, worth GB...

Arix Bioscience says Imara to merge with Enliven Therapeutics
14 Oct 2022

Arix Bioscience says Imara to merge with Enliven Therapeutics

(Alliance News) - Arix Bioscience PLC on Friday said its portfolio company Imara Inc has signed a merger deal with Enliven Therapeutics Inc.

DIRECTOR DEALINGS: M&G chair and new CEO buy GBP450,000 in shares
10 Oct 2022

DIRECTOR DEALINGS: M&G chair and new CEO buy GBP450,000 in shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and last week and ...

IN BRIEF: Arkle Resources restarts drilling at Stonepark project
15 Sep 2022

IN BRIEF: Arkle Resources restarts drilling at Stonepark project

Arkle Resources PLC - Ireland-based gold and zinc explorer - Says that Group Eleven Resources Corp, its partner and operator for the Stonepark project...

Arix Bioscience NAV falls; portfolio firm Disc to merge with Gemini
12 Aug 2022

Arix Bioscience NAV falls; portfolio firm Disc to merge with Gemini

(Alliance News) - Arix Bioscience PLC on Thursday reported a decline in net asset value as public biotech markets did not perform well.